[1] |
中华医学会神经病学分会. 中国自身免疫性脑炎诊治专家共识[J]. 中华神经科杂志, 2017, 50(2): 91-98.
|
[2] |
Gibson LL, McKeever A, Coutinho E, et al. Cognitive impact of neuronal antibodies: encephalitis and beyond[J]. Transl Psychiatry, 2020, 10(1): 304.
doi: 10.1038/s41398-020-00989-x
|
[3] |
Li X, Hou C, Wu WL, et al. Pediatric anti-N-methyl-D-aspartate receptor encephalitis in southern China: analysis of 111 cases[J]. J Neuroimmunol, 2021, 352: 577479.
doi: 10.1016/j.jneuroim.2021.577479
|
[4] |
Cainelli E, Nosadini M, Sartori S, et al. Neuropsychological and psychopathological profile of anti-NMDAR encephalitis: a possible pathophysiological model for pediatric neuropsychiatric disorders[J]. Arch Clin Neuropsychol, 2019, 34(8): 1309-1319.
doi: 10.1093/arclin/acy088
|
[5] |
Matricardi S, Patrini M, Freri E, et al. Cognitive and neuropsychological evolution in children with anti-NMDAR encephalitis[J]. J Neurol, 2016, 263(4): 765-771.
doi: 10.1007/s00415-016-8056-9
pmid: 26886205
|
[6] |
Aarsen FK, van Oosterhout MP, et al. Long-term neuropsychological outcome following pediatric anti-NMDAR encephalitis[J]. Neurology, 2018, 90(22): e1997-e2005.
doi: 10.1212/WNL.0000000000005605
|
[7] |
Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis[J]. Lancet Neurol, 2016, 15(4): 391-404.
doi: 10.1016/S1474-4422(15)00401-9
pmid: 26906964
|
[8] |
van Swieten JC, Koudstaal PJ, Visser MC, et al. Interobserver agreement for the assessment of handicap in stroke patients[J]. Stroke, 1988, 19(5): 604-607.
doi: 10.1161/01.str.19.5.604
pmid: 3363593
|
[9] |
Cellucci T, Van Mater H, Graus F, et al. Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient[J]. Neurol Neuroimmunol Neuroinflamm, 2020, 7(2): e663.
doi: 10.1212/NXI.0000000000000663
|
[10] |
张厚粲. 韦氏儿童智力量表第四版(WISC-IV)中文版的修订[J]. 心理科学, 2009, 32(5): 1177-1179.
|
[11] |
Lynch DR, Rattelle A, Dong YN, et al. Anti-NMDA receptor encephalitis: clinical features and basic mechanisms[J]. Adv Pharmacol, 2018, 82: 235-260.
|
[12] |
Huang Q, Xie Y, Hu Z, et al. Anti-N-methyl-D-aspartate receptor encephalitis: a review of pathogenic mechanisms, treatment, prognosis[J]. Brain Res, 2020, 1727: 146549.
doi: 10.1016/j.brainres.2019.146549
|
[13] |
McKeon GL, Robinson GA, Ryan AE, et al. Cognitive outcomes following anti-N-methyl-D-aspartate receptor encephalitis: a systematic review[J]. J Clin Exp Neuropsychol, 2018, 40(3): 234-252.
doi: 10.1080/13803395.2017.1329408
pmid: 28585453
|
[14] |
McKeon GL, Scott JG, Spooner DM, et al. Cognitive and social functioning deficits after anti-N-methyl-D-aspartate receptor encephalitis: an exploratory case series[J]. J Int Neuropsychol Soc, 2016, 22(8): 828-838.
doi: 10.1017/S1355617716000679
pmid: 27546201
|
[15] |
Finke C, Kopp UA, Prüss H, et al. Cognitive deficits following anti-NMDA receptor encephalitis[J]. J Neurol Neurosurg Psychiatry, 2012, 83(2): 195-198.
doi: 10.1136/jnnp-2011-300411
pmid: 21933952
|
[16] |
Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study[J]. Lancet Neurol, 2013, 12(2): 157-165.
doi: 10.1016/S1474-4422(12)70310-1
pmid: 23290630
|
[17] |
Broadley J, Seneviratne U, Beech P, et al. Prognosticating autoimmune encephalitis: a systematic review[J]. J Autoimmun, 2019, 96: 24-34.
doi: S0896-8411(18)30487-6
pmid: 30595145
|
[18] |
Howarth RA, Vova J, Blackwell LS. Early functional outcomes for pediatric patients diagnosed with anti-N-methyl-D-aspartate receptor encephalitis during inpatient rehabilitation[J]. Am J Phys Med Rehabil, 2019, 98(7): 529-535.
doi: 10.1097/PHM.0000000000001087
|
[19] |
徐玄玄, 靳培娜, 马威, 等. 抗NMDAR脑炎患儿痫性发作临床特征及预后[J]. 临床儿科杂志, 2020, 38(5): 367-369.
|